GastroMARK

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved May 1996

Specific Treatments:

gastrointestinal forms of cancer

Find Related Trials for The Following Conditions

General Information

GastroMark has been approved as a magnetic resonance imaging agent for the gastrointestinal tract. Administered orally, GastroMark enhances the contrast between the bowel and other abdominal structures and masses in MRI images.